10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2015

OR

oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from        to        

Commission File Number 1-6549

American Science and Engineering, Inc.

(Exact name of Registrant as specified in its charter)

Massachusetts	04-2240991
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
829 Middlesex Turnpike
Billerica, Massachusetts	01821
(Address of principal executive offices)	(Zip Code)

(978) 262-8700

(Registrant’s telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes x  No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes x  No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer o	Accelerated filer x
Non-accelerated filer o  (Do not check if a smaller reporting company)	Smaller reporting company o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Securities Exchange Act of 1934).  Yes o  No x

The number of shares of the registrant’s common stock, $0.66 2/3 par value, outstanding as of November 3, 2015 was 7,167,424.

TABLE OF CONTENTS

Part I — Financial Information
Item 1 — Financial Statements	3
Unaudited Condensed Consolidated Balance Sheets — September 30, 2015 and March 31, 2015	3
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)— For the three and six months ended September 30, 2015 and September 30, 2014	4
Unaudited Condensed Consolidated Statements of Cash Flows — For the six months ended September 30, 2015 and September 30, 2014	5
Notes to Unaudited Condensed Consolidated Financial Statements	6
Item 2 — Management’s Discussion and Analysis of Financial Condition and Results of Operations	12
Item 3 — Quantitative and Qualitative Disclosure About Market Risk	15
Item 4 — Controls and Procedures	15
Part II — Other Information
Item 1A — Risk Factors	16
Item 2 — Unregistered Sales of Equity Securities and Use of Proceeds	16
Item 6 —Exhibits	16
Signatures	17

2

PART I — FINANCIAL INFORMATION

ITEM 1 — FINANCIAL STATEMENTS

AMERICAN SCIENCE AND ENGINEERING, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(In thousands, except share and per share amounts)	September 30, 2015			March 31, 2015
Assets
Current assets:
Cash and cash equivalents	$	79,293		$	68,835
Restricted cash	5,596			6,193
Short-term investments, at fair value	7,694			24,533
Accounts receivable, net of allowances of $250 and $333 at September 30, 2015 and March 31, 2015, respectively	20,873			22,124
Unbilled costs and fees	3,478			1,848
Inventories, net	38,329			40,983
Prepaid expenses and other current assets	8,823			10,701
Deferred income taxes	2,486			2,486
	275,700			275,700
Total current assets	166,572			177,703
Equipment and leasehold improvements, net	7,117			8,711
Restricted cash	231			208
Deferred income taxes	5,952			5,952
Other assets, net	301			534
Total assets	$	180,173		$	193,108
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable	$	4,747		$	7,200
Accrued salaries and benefits	4,549			6,769
Accrued warranty costs	200			159
Deferred revenue	8,653			7,355
Customer deposits	11,557			13,956
Other current liabilities	4,579			5,736
Total current liabilities	34,285			41,175
Deferred revenue	3,344			1,019
Other long-term liabilities	622			507
Total liabilities	38,251			42,701
Stockholders’ equity:
Preferred stock, no par value, 100,000 shares authorized; no shares issued	—			—
Common stock, $0.66 2/3 par value, 20,000,000 shares authorized; 7,163,642 and 7,193,247 shares issued and outstanding at September 30, 2015 and March 31, 2015, respectively	4,775			4,795
Capital in excess of par value	2,126			3,334
Accumulated other comprehensive loss, net	(7		)	(11		)
Retained earnings	135,028			142,289
Total stockholders’ equity	141,922			150,407
Total liabilities and stockholders’ equity	$	180,173		$	193,108

The accompanying notes are an integral part of these condensed consolidated financial statements.

3

AMERICAN SCIENCE AND ENGINEERING, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

(Unaudited)

	Three Months Ended						Six Months Ended
(In thousands, except per share amounts)	September 30, 2015			September 30, 2014			September 30, 2015			September 30, 2014
Net sales and contract revenues:
Net product sales and contract revenues	$	13,425		$	11,004		$	32,566		$	34,255
Net service revenues	11,712			12,062			24,015			24,348
Total net sales and contract revenues	25,137			23,066			56,581			58,603
Cost of sales and contracts:
Cost of product sales and contracts	7,045			6,531			17,665			18,829
Cost of service revenues	5,738			6,852			12,136			13,622
Total cost of sales and contracts	12,783			13,383			29,801			32,451
Gross profit	12,354			9,683			26,780			26,152
Expenses:
Selling, general and administrative expenses	6,772			9,118			15,042			17,309
Research and development costs	4,751			6,418			11,640			12,424
Total operating expenses	11,523			15,536			26,682			29,733
Operating income (loss)	831			(5,853		)	98			(3,581		)
Other income (expense):
Interest and investment income	55			87			89			165
Interest expense	—			(9		)	—			(19		)
Other, net	(172		)	(99		)	(265		)	(252		)
Total other expense	(117		)	(21		)	(176		)	(106		)
Income (loss) before provision for (benefit from) income taxes	714			(5,874		)	(78		)	(3,687		)
Provision for (benefit from) income taxes	250			(1,968		)	(27		)	(1,235		)
Net income (loss)	$	464		$	(3,906	)	$	(51	)	$	(2,452	)
Other comprehensive income (loss):
Unrealized gain (loss) on available for sale securities (net of tax)	3			(15		)	4			(29		)
Comprehensive income (loss)	$	467		$	(3,921	)	$	(47	)	$	(2,481	)
Income (loss) per share — Basic	$	0.06		$	(0.49	)	$	(0.01	)	$	(0.31	)
Income (loss) per share — Diluted	$	0.06		$	(0.49	)	$	(0.01	)	$	(0.31	)
Weighted average shares — Basic	7,151			7,917			7,156			7,904
Weighted average shares — Diluted	7,156			7,917			7,156			7,904
Dividends declared per share	$	0.50		$	0.50		$	1.00		$	1.00

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

AMERICAN SCIENCE AND ENGINEERING, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	For the Six Months Ended
(In thousands)	September 30, 2015			September 30, 2014
Cash flows from operating activities:
Net loss	$	(51	)	$	(2,452	)
Adjustments to reconcile net loss to net cash provided by (used for) operating activities:
Depreciation and amortization	1,965			2,605
Provisions for contracts, inventory and accounts receivable reserves	(80		)	(270		)
Amortization of bond premium	63			540
Stock compensation expense	1,044			1,770
Other	202			—
Changes in assets and liabilities:
Accounts receivable	1,326			4,878
Unbilled costs and fees	(1,630		)	(3,272		)
Inventories	2,659			(11,534		)
Prepaid expenses and other assets	2,111			(5,436		)
Accounts payable	(2,453		)	(6,762		)
Accrued income taxes	—			(2,338		)
Customer deposits	(2,399		)	5,433
Deferred revenue	3,623			(1,847		)
Accrued expenses and other liabilities	(3,221		)	(7,274		)
Net cash provided by (used for) operating activities	3,159			(25,959		)
Cash flows from investing activities:
Purchases of short-term investments	—			(29,212		)
Proceeds from sales and maturities of short-term investments	16,780			40,933
Purchases of property and equipment, net	(573		)	(943		)
Net cash provided by investing activities	16,207			10,778
Cash flows from financing activities:
Decrease in restricted cash	574			726
Proceeds from exercise of stock options	—			888
Repurchase of shares of common stock	(2,263		)	—
Repayment of leasehold financing liability	—			(754		)
Payment of common stock dividend	(7,219		)	(7,993		)
Net cash used for financing activities	(8,908		)	(7,133		)
Net increase (decrease) in cash and cash equivalents	10,458			(22,314		)
Cash and cash equivalents at beginning of period	68,835			62,143
Cash and cash equivalents at end of period	$	79,293		$	39,829

The accompanying notes are an integral part of these condensed consolidated financial statements.

5

AMERICAN SCIENCE AND ENGINEERING, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1.   GENERAL

The condensed consolidated financial statements include the accounts of American Science and Engineering, Inc. and its wholly owned subsidiaries (the “Company”). All significant intercompany transactions and balances have been eliminated.

The unaudited condensed consolidated financial statements have been prepared in accordance with the requirements of Form 10-Q and consequently do not include all disclosures required by Form 10-K. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2015, or fiscal 2015, as filed with the Securities and Exchange Commission on June 5, 2015.

The unaudited condensed consolidated financial statements, in the opinion of management, include all necessary adjustments, consisting solely of normal recurring adjustments, to present fairly the Company’s financial position, results of operations and cash flows.  These results are not necessarily indicative of the results to be expected for the entire year.

Nature of Operations

The Company develops, manufactures, markets, and sells X-ray inspection and other detection products for homeland security, force protection, public safety and other critical defense and security applications.  The Company provides maintenance, warranty, engineering, and training and operator services related to these products.  The Company has one reporting segment, X-ray screening products.

Significant Accounting Policies

For systems that are produced in a standard manufacturing operation and have shorter order to delivery cycles, the Company recognizes sales when title passes and when other revenue recognition criteria (such as transfer of risk and customer acceptance) are met.  Revenues on cost reimbursable and custom long-term fixed price contracts are generally recorded as costs are incurred using the percentage of completion method.

The other significant accounting policies followed by the Company and its subsidiaries in preparing its consolidated financial statements are set forth in Note 1 to the consolidated financial statements included in its Form 10-K for the year ended March 31, 2015.  There have been no changes to the Company’s critical accounting policies during the three and six months ended September 30, 2015.

Stock Repurchase Program

On May 7, 2013, the Board of Directors announced the approval of its fifth Stock Repurchase Program which authorized the Company to repurchase up to $35 million of shares of its common stock from time to time on the open market or in privately negotiated transactions.  On December 1, 2014, the Board of Directors announced an expansion of this stock repurchase program increasing the program authorization to $50 million of shares of its common stock.

During the three months ended June 30, 2015, the Company repurchased 54,056 shares of its common stock at an average price of $41.86.  During the three months ended September 30, 2015, the Company did not repurchase any shares of its common stock.  As of September 30, 2015, the remaining balance available under the Stock Repurchase Program was $11,225,000.

Dividends

	Three Months Ended				Six Months Ended
(In thousands)	September 30, 2015		September 30, 2014		September 30, 2015		September 30, 2014
Dividends declared	$	0.50	$	0.50	$	1.00	$	1.00
Dividends paid	$	0.50	$	0.50	$	1.00	$	1.00

On November 9, 2015, the Company declared a cash dividend of $0.50 per share. The dividend will be paid on December 2, 2015 to all shareholders of record at the close of business on November 24, 2015.  Future dividends will be declared at the discretion of the Board of Directors and will depend upon such factors as the Board of Directors deems relevant.

Concentrations of Credit Risk

Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents, restricted cash, short-term investments and accounts and unbilled receivables.  At times, the Company maintains

6

cash balances in excess of insured limits. The Company maintains its cash and cash equivalents with major financial institutions.  The Company’s credit risk is managed by investing its cash in investment grade corporate debentures/bonds, U.S. government agency bonds, commercial paper, U.S. treasury bills, money market funds, and certificates of deposit.

New Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue From Contracts With Customers, which outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The ASU is based on the principle that an entity should recognize revenue in an amount that reflects the consideration to which an entity expects to be entitled in exchange for the goods or services transferred to its customers. The ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to fulfill a contract. Entities have the option of using either a full retrospective or a modified retrospective approach for the adoption of the new standard. The guidance is effective for annual periods beginning on or after December 15, 2017 (early adoption for annual periods beginning on or after December 15, 2016 is permitted). The Company is currently assessing the impact that this standard will have on its consolidated financial statements.

In January 2015 the FASB issued ASU No. 2015-01, Income Statement—Extraordinary and Unusual Items, which eliminates from U.S. GAAP the concept of extraordinary items.  Entities may apply the amendments prospectively or retrospectively to all prior periods presented in the financial statements. Early adoption is permitted.  ASU No. 2015-01 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015.  The adoption of this standard is not expected to have a material effect on the Company’s consolidated financial statements.

In July 2015, the FASB issued ASU No. 2015-11, Simplifying the Measurement of Inventory, which requires an entity to measure inventory at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Subsequent measurement is unchanged for inventory measured using last-in, first-out (“LIFO”) or the retail inventory method. It is effective for annual reporting periods beginning after December 15, 2016. The amendments should be applied prospectively with earlier application permitted as of the beginning of an interim or annual reporting period. The Company is currently assessing the impact that this standard will have on its consolidated financial statements.

2.   ACCOUNTING FOR STOCK-BASED COMPENSATION

The Company accounts for stock-based awards made to its employees and Board of Directors in accordance with FASB Accounting Standards Codification (“FASB ASC”) 718, Compensation—Stock Compensation, which requires the measurement and recognition of all compensation costs for stock-based awards made to employees and the Board of Directors based upon the grant date fair value over the requisite service period for awards expected to vest.

The Company recognized $710,000 and $991,000 of stock-based compensation costs for the three months ended September 30, 2015 and September 30, 2014, respectively.  The Company recognized $1,044,000 and $1,770,000 of stock-based compensation costs for the six months ended September 30, 2015 and September 30, 2014, respectively.  The income tax benefit recognized related to the compensation costs for the three months ended September 30, 2015 and September 30, 2014 was approximately $249,000 and $332,000 respectively.  The income tax benefit recognized related to the compensation costs for the six months ended September 30, 2015 and September 30, 2014 was approximately $366,000 and $593,000, respectively.

The following table summarizes stock-based compensation costs included in the Company’s consolidated statements of operations and comprehensive income (loss):

	Three Months Ended				Six Months Ended
(In thousands)	September 30, 2015		September 30, 2014		September 30, 2015		September 30, 2014
Cost of sales and contracts	$	148	$	297	$	113	$	523
Selling, general and administrative	562		694		931		1,247
Total share-based compensation expense before tax	$	710	$	991	$	1,044	$	1,770

Stock Option and Other Compensation Plans

The Company has various stock option and other compensation plans for directors, officers, and employees.  The Company had the following stock plans outstanding as of September 30, 2015: the 2003 Stock Plan for Non-Employee Directors, the 2005 Equity and Incentive Plan and the 2014 Equity and Incentive Plan. There are 367,000 shares remaining available for issuance under these plans. Vesting periods are at the discretion of the Board of Directors and typically range from one to three years.  Options under these plans are granted at fair market value and have a term of ten years from the date of grant.

7

Stock Options

The following tables summarize stock option activity for the six months ended September 30, 2015:

	Number of Shares		Weighted Average Exercise Price ($)		Weighted Average Contractual Life (years)	Aggregate Intrinsic Value
Options outstanding at March 31, 2015	191,834		$	66.03	2.88
Grants	—		—
Exercises	—		—			—
Cancellations	(4,721	)	56.92
Options outstanding at September 30, 2015	187,113		$	66.26	2.42
Options exercisable at September 30, 2015	187,113

Information related to the stock options outstanding as of September 30, 2015 is as follows:

Range of Exercise Prices	Number of Shares	Weighted-Average Remaining Contractual Life (years)	Weighted-Average Exercise Price ($)		Exercisable Number of Shares	Exercisable Weighted-Average Exercise Price ($)
$ 53.55-$60.00	24,450	0.07	$	53.55	24,450	$	53.55
$ 60.01-$75.82	162,663	2.78	68.17		162,663	68.17
$ 53.55-$75.82	187,113	2.42	$	66.26	187,113	$	66.26

The Company deems the Black-Scholes option pricing model as the most appropriate method for determining the estimated fair value of stock-based awards. The Black-Scholes method of valuation requires several assumptions: (1) the expected term of the stock-based award; (2) the expected future stock volatility over the expected term; (3) a risk-free interest rate; and (4) the expected dividend yield. The expected term represents the expected period of time that the Company believes the options will be outstanding based on historical information. Estimates of expected future stock price volatility are based on the historic volatility of the Company’s common stock and the risk-free interest rate is based on the U.S. Zero-Bond rate.

There were no options granted in the three or six month period ended September 30, 2015.

As of September 30, 2015, there was no remaining unrecognized compensation cost related to options granted.

Restricted Stock and Restricted Stock Units

The Company has instituted long-term incentive plans for certain key employees. These plans call for the issuance of restricted stock, restricted stock units, restricted stock options, and/or cash incentives which vest or are paid upon the achievement of certain performance-based goals as well as service time incurred.  Restricted stock and restricted stock units may also be granted to other employees with vesting periods that range from one to three years.  In addition, annually the non-employee directors are granted restricted stock. Restricted stock shares granted to our non-employee directors vest on a pro-rata basis, based on service performed over a one-year period. Certain of the stock and stock unit awards contain rights to receive non-forfeitable dividends. The fair values of the restricted stock and restricted stock unit awards are equal to the fair value of the Company’s common stock on the date of grant.

Non-vested restricted stock and restricted stock unit awards are subject to the risk of forfeiture until the fulfillment of specified conditions. As of September 30, 2015, there was $6,578,000 of total unrecognized compensation costs related to non-vested restricted stock and restricted stock unit awards granted under the Company’s stock plans. These costs are expected to be recognized over a weighted average period of 1.7 years.

The following table summarizes the status of the Company’s non-vested restricted stock and restricted stock unit awards for the six months ended September 30, 2015:

8

	Number of Shares		Weighted Average Grant Date Fair Value ($)
Outstanding at March 31, 2015	91,837		$	62.99
Granted	119,439		43.78
Vested	(15,332	)	58.95
Forfeited	(7,838	)	63.65
Outstanding at September 30, 2015	188,106		$	51.09

3.INVENTORIES

Inventories consist of material, labor and manufacturing overhead and are recorded at the lower of cost, using the weighted average cost method, or net realizable value. Excess manufacturing overhead costs attributable to idle facility expenses, freight, handling costs and wasted material (spoilage) attributable to abnormally low production volumes (levels that materially differ from budgeted production plans due primarily to changes in customer demand) are excluded from inventory and recorded as an expense in the period incurred.

The components of inventories at September 30, 2015 and March 31, 2015 were as follows:

(In thousands)	September 30, 2015		March 31, 2015
Raw materials, completed sub-assemblies, and spare parts	$	20,451	$	20,334
Work-in-process	13,092		17,853
Finished goods	4,786		2,796
Total	$	38,329	$	40,983

4.INCOME PER COMMON AND COMMON EQUIVALENT SHARE

Basic earnings per common share is computed by dividing distributed and undistributed earnings to common stockholders by the weighted average number of shares of common stock outstanding during the period.   Share-based payment awards entitling holders to receive non-forfeitable dividends before vesting are considered participating securities and thus are included in the calculation of basic earnings per share under the two-class method.  Diluted earnings per share include the dilutive impact of options, and restricted stock units using the average share price of the Company’s common stock for the period.  For the three months ended September 30, 2015 and September 30, 2014, common stock equivalents of 291,000 and 298,000 shares, respectively, are excluded from diluted earnings per share, as their effect is anti-dilutive. For the six months ended September 30, 2015 and September 30, 2014, common stock equivalents of 291,000 and 294,000 shares, respectively, are excluded from diluted earnings per share, as their effect is anti-dilutive.

	Three Months Ended					Six Months Ended
(In thousands except per share amounts)	September 30, 2015		September 30, 2014			September 30, 2015			September 30, 2014
Income (Loss) Per Share — Basic:
Net income (loss)	$	464	$	(3,906	)	$	(51	)	$	(2,452	)
Less: Distributed and undistributed earnings (loss) to unvested restricted stock units	7		—			(6		)	—
Distributed and undistributed earnings (loss) to common shareholders — Basic	457		(3,906		)	(45		)	(2,452		)
Weighted average number of common shares outstanding — basic	7,151		7,917			7,156			7,904
Net income (loss) per share — basic	$	0.06	$	(0.49	)	$	(0.01	)	$	(0.31	)
Diluted:
Weighted average number of common shares outstanding	7,151		7,917			7,156			7,904
Add dilutive effect of potential common shares	5		—			—			—
Weighted average number of common and potential common shares outstanding — diluted	7,156		7,917			7,156			7,904
Net income (loss) per share — diluted	$	0.06	$	(0.49	)	$	(0.01	)	$	(0.31	)

5.   LETTERS OF CREDIT

In the normal course of business, the Company may provide certain customers and potential customers with performance

9

guarantees, which are generally backed by standby letters of credit. In general, the Company would only be liable for the amount of these guarantees in the event of default in the performance of its obligations, the probability of which management believes is low.   As of September 30, 2015, the Company had outstanding $10,817,000 in standby letters of credit.  These outstanding standby letters of credit are cash-secured at amounts ranging from 52% to 63% of the outstanding letters of credit, resulting in restricted cash balance of $5,827,000 at September 30, 2015, of which $231,000 was considered long-term restricted cash and investments due to the expiration date of the underlying letters of credit.

6.   FAIR VALUE MEASUREMENTS

The Company has categorized its financial assets, based on the priority of the inputs to the valuation technique, into a three-level fair value hierarchy as set forth below. If the inputs used to measure a financial instrument fall within different levels of the hierarchy, the categorization of such financial asset is based on the lowest level input that is significant to the fair value measurement of such instrument.

Financial assets are categorized based on the inputs to the valuation techniques as follows:

Level 1 - Financial assets whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the Company has the ability to access at the measurement date (examples include actively exchange-traded equity securities, listed derivatives, and most U.S. government and agency securities).

Level 2 - Financial assets whose values are based on quoted prices in markets where trading occurs infrequently or whose values are based on quoted prices of instruments with similar attributes in active markets.  Level 2 inputs include the following:

·Quoted prices for identical or similar assets or liabilities in non-active markets;

·Inputs other than quoted prices that are observable for substantially the full term of the asset or liability; and

·Inputs that are derived principally from or corroborated by observable market data for substantially the full term of the asset or liability.

Level 3 - Financial assets whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s assumptions about the assumptions a market participant would use in pricing the asset or liability. The Company currently does not have any Level 3 financial assets or liabilities.

The following table presents the financial assets that the Company measures at fair value on a recurring basis, based on the fair value hierarchy as of September 30, 2015 and March 31, 2015:

(In thousands)	September 30, 2015		March 31, 2015
Level 1 — Financial Assets
Money market funds	$	58,755	$	51,784
Treasury bills	—		5,403
Total Level 1 Financial Assets	58,755		57,187
Level 2 — Financial Assets
Corporate debentures/bonds	5,890		13,813
Government agency bonds	1,804		5,317
Total Level 2 Financial Assets	7,694		19,130
Total cash equivalents and short-term investments	$	66,449	$	76,317

Short-term investments are classified as available-for-sale and are recorded at their fair market values using the specific identification method. As of September 30, 2015, all of the Company’s available-for-sale securities had contractual maturities of seven months or less. The Company had no material realized gains or losses on its available-for-sale securities for the three and six months ended September 30, 2015 and September 30, 2014. The unrealized holding gains or losses on these securities are included as a component of other comprehensive income (loss), as disclosed in the condensed consolidated statements of operations and comprehensive income (loss).

10

(In thousands)	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
September 30, 2015:
Short-term investments:
Corporate debentures/bonds	$	5,890	$	—	$	—	$	5,890
Government agency bonds	1,804		—		—		1,804
Total short-term investments	$	7,694	$	—	$	—	$	7,694
Cash equivalents:
Money market funds	$	58,755	—		—		$	58,755
Total cash equivalents	$	58,755	$	—	$	—	$	58,755

(In thousands)	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
March 31, 2015:
Short-term investments:
Corporate debentures/bonds	$	13,823	$	—	$	(10	)	$	13,813
Government agency bonds	5,315		2		—			5,317
Treasury bills	5,400		3		—			5,403
Total short-term investments	$	24,538	$	5	$	(10	)	$	24,533
Cash equivalents:
Money market funds	$	51,784	$	—	$	—		$	51,784
Total cash equivalents	$	51,784	$	—	$	—		$	51,784

7.   INCOME TAXES

The Company accounts for income taxes in accordance with FASB ASC 740, Income Taxes, and recognizes deferred income taxes based on the expected future tax consequences of differences between the financial statement basis and the tax basis of assets and liabilities, calculated using enacted tax rates in effect for the year in which the differences are expected to be reflected in the tax return. The Company evaluates the need for a valuation allowance against its net deferred tax assets at period end based upon its three year cumulative income and its projections of future income, and records a valuation allowance against any net deferred tax assets if it is more likely than not that they will not be realized.

The Company is currently open to audit under the statute of limitations by the Internal Revenue Service for the years ending March 31, 2012 through 2014 and by various state taxing authorities for the years ending March 31, 2011 through 2014.

8.     GUARANTEES

Certain of the Company’s products carry a one-year warranty, the costs of which are accrued for at the time of shipment or delivery.  Accrual rates are based upon historical experience for the trailing twelve months and management’s judgment of future exposure.  Warranty experience for the three and six months ended September 30, 2015 and 2014 was as follows:

	Three Months Ended						Six Months Ended
(In thousands)	September 30, 2015			September 30, 2014			September 30, 2015			September 30, 2014
Warranty accrual - beginning of period	$	188		$	246		$	159		$	404
Accruals for warranties issued during the period	83			43			174			85
Adjustment of preexisting accrual estimates	1			(16		)	36			(160		)
Warranty costs incurred during the period	(72		)	(87		)	(169		)	(143		)
Warranty accrual — end of period	$	200		$	186		$	200		$	186

9.   LEASE COMMITMENTS

In March 2005, the Company renewed its lease agreement for its corporate headquarters and manufacturing facilities in Billerica, Massachusetts.  As part of the lease agreement, the Company’s landlord agreed to certain renovations to the Billerica facility including the construction of additional high bay manufacturing space.  The Company was responsible for a portion of the construction costs and was deemed to be the owner of the building during the construction period under FASB ASC 840, Leases.

In October 2014, the Company entered into an amendment of its lease agreement for the Billerica facilities extending the term of the lease through February 28, 2023 with an adjusted rent schedule commencing October 1, 2014. Due to certain provisions of

11

the amended lease agreements which removed certain continuing financing obligations related to the building, it was determined that the lease no longer qualified as a capital lease and as such, the Company removed the capitalized building, associated accumulated depreciation and lease financing liability from its books.  The associated gain of $381,000 resulting from the removal of the building from our books was deferred and is being amortized over the modified lease term of the property.

10.   COMMITMENTS AND CONTINGENCIES

Deferred Revenue

The Company offers extended warranty and service contracts to its customers. These contracts typically cover a period of one to five years, and include advance payments that are recorded as deferred revenue. Revenue is recognized as services are performed over the life of the contract, which represents the period over which these revenues are earned. Costs associated with these extended warranty and service contracts are expensed to cost of sales and contracts as incurred.

Legal Matters

The Company continues to respond to the subpoena received from the Office of the Inspector General (“OIG”) of the U.S. General Services Administration (“GSA”) on April 17, 2015 with respect to the investigation being conducted by the GSA and the Department of Defense.  The investigation relates to the Company’s discount practices and compliance with the pricing provisions of the Company’s GSA Schedule contract. The Company continues to cooperate fully with the investigation and at this time management is unable to predict the outcome of the investigation or estimate the amount of possible loss or range of loss with any certainty.  It is possible that the investigation could lead to claims or findings of violations of the False Claims Act in connection with the Company’s GSA contracting activity. Violations of the False Claims Act could result in the imposition of damages, including up to treble damages, plus civil penalties in some cases. The Company has incurred, and will continue to incur, legal costs in connection with the investigation, and could incur other costs, damages or penalties, depending on its outcome, which could be material.

ITEM 2 — MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This Quarterly Report on Form 10-Q contains forward-looking statements that involve risks and uncertainties. For this purpose, any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934.  Without limiting the foregoing, the words “believes”, “anticipates”, “plans”, “expects”, “intends”, “should” and similar expressions are intended to identify forward-looking statements.  These statements are not guarantees of future performance and involve certain risks, uncertainties, and assumptions that are difficult to predict, and you should not place undue reliance on our forward-looking statements.  The factors referred to under “Item 1A. Risk Factors”, among others, could cause actual results to differ materially from those indicated by forward-looking statements made herein and presented elsewhere by management from time to time.  We expressly disclaim any obligation to update or alter our forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Overview

American Science and Engineering, Inc. develops and manufactures X-ray inspection systems for homeland security, force protection, public safety and other critical defense applications.   We provide maintenance, warranty, engineering, and training related to these products.

Our primary technologies are Z Backscatter technology, which is used to detect explosives, illegal drugs, and other contraband even when concealed in complex backgrounds, and other technologies that expand the detection capability of our products beyond the material discrimination features of the Z Backscatter technology to include the penetration capability of high-energy transmission X-rays for dense cargos and/or other detection techniques.

Net sales and contract revenues for the second quarter of fiscal year ending March 31, 2016, or fiscal 2016, increased to $25,137,000 compared to revenues of $23,066,000 for the second quarter of fiscal 2015. We reported operating income of $831,000 for the second quarter of fiscal 2016 compared to an operating loss of $5,853,000 for the second quarter of fiscal 2015.  Net income for the second quarter of fiscal 2016 was $464,000 ($0.06 per share, on a diluted basis) compared to net loss of $3,906,000 ($0.49 per share, on a diluted basis) for the second quarter of fiscal 2015. These results represent a 9% increase in revenues, a $6,684,000 increase in operating income and a $0.55 increase in earnings per share when compared to results for the second quarter of fiscal 2015.

Net sales and contract revenues for the first six months of fiscal year ending March 31, 2016, or fiscal 2016, decreased to $56,581,000 compared to revenues of $58,603,000 for the first six months of fiscal 2015. We reported operating income of

12

$98,000 for the first six months of fiscal 2016 compared to an operating loss of $3,581,000 for the first six months of fiscal 2015.  Net loss for the first six months of fiscal 2016 was $51,000 ($0.01 loss per share, on a diluted basis) compared to net loss of $2,452,000 ($0.31 loss per share, on a diluted basis) for the first six months of fiscal 2015. These results represent a 3% decrease in revenues, a $3,679,000 increase in operating income and a $0.30 increase in earnings per share when compared to results for the second quarter of fiscal 2015.

The following table presents net sales and contract revenues by product and service categories:

	Three Months Ended				Six Months Ended
(In thousands)	September 30, 2015		September 30, 2014		September 30, 2015		September 30, 2014
Cargo Inspection Systems	$	681	$	4,035	$	9,590	$	13,181
Mobile Cargo Inspection Systems	9,210		2,772		16,318		14,335
Parcel and Personnel Screening Inspection Systems	2,317		1,534		4,823		2,299
Other product sales and contract revenue	1,217		2,663		1,835		4,440
Total net product sales and contract revenues	13,425		11,004		32,566		34,255
Net service revenues	11,712		12,062		24,015		24,348
Total net sales and contract revenues	$	25,137	$	23,066	$	56,581	$	58,603

Critical Accounting Policies

We believe that several accounting policies are important to understanding our historical and future performance. We refer to these policies as “critical” because these specific areas generally require us to make judgments and estimates about matters that are uncertain at the time we make the estimate, and different estimates—which also would have been reasonable—could have been used, which would have resulted in different financial results.

The critical accounting policies we identified in our most recent Annual Report on Form 10-K for the fiscal year ended March 31, 2015 are policies related to revenue recognition, inventories and related allowances for obsolete and excess inventory, and income taxes. It is important that the discussion of our operating results that follows be read in conjunction with the critical accounting policies disclosed in our Annual Report on Form 10-K, as filed with the Securities and Exchange Commission on June 5, 2015.  There have been no changes to our critical accounting policies during the three month period ended September 30, 2015.

Results of Operations

Net sales and contract revenues for the second quarter of fiscal 2016 increased by $2,071,000 to $25,137,000 compared to the net sales and contract revenues of $23,066,000 for the corresponding period in the prior fiscal year.  Product sales and contract revenues increased by $2,421,000 from the prior year due primarily to an increase of $6,438,000 in Mobile Cargo Inspection Systems revenues due to a higher number of units delivered as compared to the prior period and an increase in Parcel and Personnel Screening Inspection revenues of $783,000 due to our introduction of the MINI Z system in June of 2014.  These increases were offset in part by a decrease of $3,354,000 in Cargo Inspection System revenues due to delays in the fulfillment of orders in backlog due to customer site delays.   Net service revenues of $11,712,000 were down slightly from the corresponding period of the prior year due to delays in the renewal of certain service contracts.

Net sales and contract revenues for the six months of fiscal 2016 decreased by $2,022,000 to $56,581,000 compared to the net sales and contract revenues of $58,603,000 for the corresponding period in the prior fiscal year.  Product sales and contract revenues decreased by $1,689,000 from the prior year due to a decrease in Cargo Inspection Systems revenues of $3,591,000, and a decrease in aftermarket parts revenue of $2,349,000.  This decrease was offset in part by an increase of $2,524,000 in Parcel and Personnel Inspection Systems attributable to our introduction of the MINI Z system in June of 2014, and an increase of $1,983,000 in Mobile Cargo Inspection Systems revenues.  Net service revenues decreased by $333,000 to $24,015,000 as compared to the first six months of fiscal 2015 due primarily to delays in renewals of certain service contracts scheduled for renewal in the period.

Total cost of sales and contract revenues for the second quarter of fiscal 2016 decreased by $600,000 to $12,783,000 as compared to the corresponding period a year ago. Cost of product sales and contract revenues increased by $514,000 to $7,045,000 as compared to the corresponding period a year ago.  Cost of product sales and contract revenues represented 53% of revenues versus 59% of revenues for the corresponding period in the prior year.  The increase in product gross margin percentage

13

was primarily attributable to the shift in product mix in the quarter to the higher margin Mobile Cargo Inspection Systems.  The cost of service revenues for the second quarter of fiscal 2016 decreased by $1,114,000 to $5,738,000 as compared to the corresponding period a year ago.  Cost of service revenues decreased to 49% of revenues from 57% of revenues in the corresponding period.  The increase in service gross margins in the second quarter of fiscal 2016 is attributable primarily to reduced third party subcontractor costs to support systems under fixed price contracts as compared to the prior year and the refund of $594,000 in employment related taxes associated with international service engineers during the period.

Total cost of sales and contract revenues for the first six months of fiscal 2016 decreased by $2,650,000 to $29,801,000 as compared to the corresponding period a year ago. Cost of product sales and contract revenues decreased by $1,164,000 to $17,665,000 as compared to the corresponding period a year ago.  Cost of product sales and contract revenues represented 54% of revenues versus 55% of revenues for the corresponding period in the prior year. This margin improvement is attributable to the shift in the product mix from the corresponding period with a greater percentage of revenues derived from our Mobile Cargo products which historically earn higher margins than our other product groups. The cost of service revenues for the first six months of fiscal 2016 decreased by $1,486,000 to $12,136,000 as compared to the corresponding period a year ago.  Cost of service revenues decreased to 51% of revenues from 56% of revenues in the corresponding period.  The increase in gross margin percentage in the first six months of fiscal 2016 as compared to the corresponding prior period is due to reduced costs to support systems under fixed price contracts and the refund of $594,000 in certain employment related taxes associated with international service engineers during the period.

Selling, general and administrative expenses for the second quarter of fiscal 2016 decreased by $2,346,000 to $6,772,000 as compared to $9,118,000 in corresponding period a year ago.  Selling, general and administrative expenses represented 27% of revenues in the current period compared to 40% for the corresponding period in the prior year. This decrease in cost was due primarily to decreases in payroll and payroll related costs of $1,160,000 resulting from headcount reductions effected over the last five quarters, a decrease in incentive compensation expense of $606,000, a decrease in consulting expenses of $121,000 and decreases in bid and proposal related costs of $234,000.

Selling, general and administrative expenses for the first six months of fiscal 2016 decreased by $2,267,000 to $15,042,000 as compared to the corresponding period a year ago.  Selling, general and administrative expenses represented 27% of revenues in the current period compared to 30% for the corresponding period in the prior year.  The decrease in selling, general and administrative expenses from the prior year period was primarily the result of a decrease in payroll and payroll related costs of $1,105,000 due to headcount reductions effected over the prior five quarters, a decrease in incentive compensation expense of $1,326,000, and a decrease in travel related expenses of $167,000 as compared to the prior period,   These decreases were offset in part by an increase in legal costs of $609,000 related to the GSA investigation,  intellectual property and other contract related matters, and an increase in consulting expenses of $203,000 as compared to the prior year.

Company funded research and development expenses for the second quarter of fiscal 2016 decreased by $1,667,000 to $4,751,000 as compared to the corresponding period a year ago.  Research and development expenses represented 19% of revenues in the current quarter compared to 28% for the corresponding period in the prior year. Research and development expenses decreased from the prior year primarily due to cost-cutting measures and headcount reductions effected during the past five quarters.  In addition, our fiscal quarter ended September 30, 2014 included research and development expenses of $350,000 in severance costs which did not recur in our fiscal quarter ended September 30, 2015.

Company funded research and development expenses for the first six months of fiscal 2016 decreased by $784,000 to $11,640,000 as compared to the corresponding period a year ago.  Research and development expenses remained consistent at 21% of revenues for both years presented. Research and development expenses decreased from the prior year primarily due to cost-cutting measures and headcount reductions effected during the past five quarters.

Other income (expense), net, was $117,000 of expense for the second quarter of fiscal 2016 as compared to $21,000 of expense for the corresponding period a year ago.  Other income (expense), net was $176,000 of expense for the first six months of fiscal 2016 as compared to $106,000 of expense for the corresponding period a year ago.   The increase in other expense was the result of reduced investment income as well as an increase in foreign currency transaction losses as compared to the prior year.

We reported pre-tax income of $714,000 in the second quarter of fiscal 2015 as compared to a pre-tax loss of $5,874,000 in the corresponding period due to the factors described above.  We reported a pre-tax loss of $78,000 in the first six months of fiscal 2016 as compared to a pre-tax loss of $3,687,000 in the corresponding period due to the factors described above.

Our effective tax rate was 35.0% for the second quarter and first six months of fiscal 2016 as compared to an effective tax rate of 33.5% for the second quarter and first six months of fiscal 2015.  The increase in the effective tax rate was due primarily decreases in projected manufacturing deductions for the year.

14

Liquidity and Capital Resources

Our primary source of liquidity is our cash flows from operations.  We believe that our operating cash flows and cash and investments on hand are sufficient for the foreseeable future to fund our working capital requirements, capital expenditures, income tax obligations, dividends payable to our shareholders and performance guarantee collateralizations and also to fund stock repurchases as desired.

Summary of Cash Activities

Cash and cash equivalents increased by $10,458,000 to $79,293,000 at September 30, 2015 compared to $68,835,000 at March 31, 2015.  Cash inflows for the period consisted primarily of:

1)net proceeds from sales and maturities of short-term investments of $16,780,000;

2)a decrease of $2,659,000 in inventories from year end due to shipments made during the period;

3)a decrease of $1,326,000 in accounts receivable due to the collection of year-end receivables;

4)an increase in deferred revenue of $3,623,000 due to advance billings effected on certain contracts during the period;

5)a decrease in restricted cash of $574,000 due to a reduction in the amount of standby letters of credit from year end; and

6)a decrease of $2,111,000 in prepaid expenses and other assets due primarily to the receipt of tax refunds during the period.

Offsetting these inflows were cash outflows including:

1)the payment of $7,219,000 in common stock dividends during the period as part of our quarterly dividend program;

2)an increase in unbilled costs and fees of $1,630,000 attributable to invoicing delays due to contract modifications on one contract;

3)the payment of $2,263,000 to repurchase 54,056 shares of our common stock during the period;

4)a decrease of $2,399,000 in customer deposits due to revenues earned during the period;

5)a decrease in accounts payable of $2,453,000 from the year end; and

6)a decrease in accrued expenses and other liabilities of $3,221,000 due to reductions in payroll and incentive compensation related accruals as compared to year end.

In the normal course of business, we may provide certain customers and potential customers with performance guarantees, which are generally backed by standby letters of credit. In general, we would only be liable for the amount of these guarantees in the event of default in the performance of our obligations; the probability of which our management believes is low.   As of September 30, 2015, we had outstanding $10,817,000 in standby letters of credit.  These outstanding standby letters of credit are cash-secured at amounts ranging from 52% to 63% of the outstanding letters of credit, resulting in restricted cash balance of $5,827,000 at September 30, 2015, of which $231,000 was considered long-term restricted cash due to the expiration date of the underlying letters of credit.

ITEM 3 — QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There were no material changes in the quantitative and qualitative information about market risk since the end of our most recent fiscal year.  For further information, see Item 7A of our Annual Report on Form 10-K for the fiscal year ended March 31, 2015, as filed with the Securities and Exchange Commission on June 5, 2015.

ITEM 4 — CONTROLS AND PROCEDURES

a)   Evaluation of disclosure controls and procedures

As of the end of the period covered by this report, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we reviewed and evaluated the effectiveness of our Company’s disclosure controls and procedures pursuant to Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 as amended (the “Exchange Act”). Based upon their evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed by the Company in the reports filed and submitted by it under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and to provide reasonable assurance that information required to be disclosed by us in such reports is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

b)   Changes in internal control over financial reporting

There have been no changes in our internal control over financial reporting as such term is defined in Rule 13a-15(f) and 15d-15(f) of the Exchange Act during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

15

PART II — OTHER INFORMATION

ITEM 1A — RISK FACTORS

You should carefully review and consider the information regarding certain factors which could materially affect our business, financial condition or future results set forth under Item 1A. “Risk Factors” in our Form 10-K for the fiscal year ended March 31, 2015 as filed with the Securities and Exchange Commission on June 5, 2015. There have been no material changes from the factors disclosed in our Form 10-K for the year ended March 31, 2015, although we may disclose changes to such factors or disclose additional factors from time to time in our future filings with the Securities and Exchange Commission.

ITEM 2 — UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

On May 7, 2013, the Board of Directors announced the approval of a Stock Repurchase Program which authorizes us to repurchase up to $35.0 million of shares of our common stock from time to time on the open market or in privately negotiated transactions. On December 1, 2014, the Board of Directors announced an expansion of this stock repurchase program increasing the program authorization to $50 million of shares of our common stock.

During the three months ended September 30, 2015, the Company did not repurchase any shares of its common stock.  As of September 30, 2015, the remaining balance available under the Stock Repurchase Program was $11,225,000.

ITEM 6 — EXHIBITS

The exhibits listed on the Exhibit Index immediately following the signature page to this Quarterly Report on Form 10-Q are incorporated herein by reference, and are filed or furnished as part of this Quarterly Report on Form 10-Q.

The information required by Exhibit Item 11 (Statement re: Computation of Income per Common and Common Equivalent Share) may be found in Note 4 to the Unaudited Condensed Consolidated Financial Statements in this quarterly report.

16

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

	AMERICAN SCIENCE AND ENGINEERING, INC.
Date: November 9, 2015	/s/ Kenneth J. Galaznik
	Kenneth J. Galaznik
	Senior Vice President, Chief Financial Officer and Treasurer (Principal Financial Officer)

17

EXHIBIT INDEX

Exhibit Number		Description of Exhibits
3.1		Restated Articles of Organization of the Company, as amended, including Certificate of Designation, Preferences, and Rights of Preferred Stock of the Company, dated April 16, 2008 (filed as Exhibit 3.1 to the Company’s filing on Form 10-K dated June 9, 2010 and incorporated herein by reference)
3.2		Amended and Restated By-laws of the Company (filed as exhibit 3.2 to the Company’s Current Report on Form 8-K filed on September 6, 2013 and incorporated herein by reference)
4.2		Rights Agreement, dated April 17, 2008, between the Company and American Stock Transfer & Trust Company (filed as Exhibit 4.1 to the Company’s filing on Form 8-A12B filed on April 18, 2008 and incorporated herein by reference)
4.3		Amendment No. 1 to Rights Agreement dated as of April 17, 2008 between American Science and Engineering and American Stock Transfer and Trust Company, LLC, as rights agent (filed as Exhibit 4.1 to the Company’s filing on Form 8-K filed on December 22, 2014 and incorporated herein by reference)
10.1	*	Form of American Science and Engineering, Inc. Time-Based Restricted Stock Unit Agreement (filed as Exhibit 10.1 to the Company’s Report on Form 8-K dated August 4, 2015 and incorporated herein by reference)
10.2	*	Form of American Science and Engineering, Inc. Performance-Based Restricted Stock Unit Agreement (filed as Exhibit 10.2 to the Company’s Report on Form 8-K dated August 4, 2015 and incorporated herein by reference)
31.1	†	Certification by Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
31.2	†	Certification by Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
32.1	†	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
32.2	†	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
101	†	The following financial information from American Science and Engineering Inc.’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2015, formatted in XBRL (eXtensible Business Reporting Language) includes: (i) Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) for the three and six months ended September 30, 2015 and 2014, (ii) Condensed Consolidated Balance Sheets at September 30, 2015 and March 31, 2015, (iii) Condensed Consolidated Statements of Cash Flows for the six months ended September 30, 2015 and 2014, and (iv) the Notes to Condensed Consolidated Financial Statements.

*  Management contract or compensatory plan or arrangement

†   Filed herewith

18

EX-31.1

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

Section 302 Certification

I, Charles P. Dougherty, certify that:

1.I have reviewed this quarterly report on Form 10-Q of American Science and Engineering, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 9, 2015	/s/ Charles P. Dougherty
	Charles P. Dougherty President and Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

Section 302 Certification

I, Kenneth J. Galaznik, certify that:

1.I have reviewed this quarterly report on Form 10-Q of American Science and Engineering, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 9, 2015	/s/ Kenneth J. Galaznik
	Kenneth J. Galaznik
	Senior Vice President, Chief Financial Officer and Treasurer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, the President and Chief Executive Officer of American Science and Engineering, Inc. (the “Company”), does hereby certify that to the undersigned’s knowledge:

1.the Company’s Report on Form 10-Q for the quarter ended September 30, 2015 (the “10-Q”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.the information contained in the 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 9, 2015	/s/ Charles P. Dougherty
	Charles P. Dougherty President and Chief Executive Officer

A signed original of this written statement required by Section 906 has been provided to American Science and Engineering, Inc. and will be retained by American Science and Engineering, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, the Senior Vice President, Chief Financial Officer and Treasurer of American Science and Engineering, Inc. (the “Company”), does hereby certify that to the undersigned’s knowledge:

1.the Company’s Report on Form 10-Q for the quarter ended September 30, 2015 (the “10-Q”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.the information contained in the 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 9, 2015	/s/ Kenneth J. Galaznik
	Kenneth J. Galaznik
	Senior Vice President, Chief Financial Officer and Treasurer

A signed original of this written statement required by Section 906 has been provided to American Science and Engineering, Inc. and will be retained by American Science and Engineering, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

XML

FAIR VALUE MEASUREMENTS (Details 2) - USD ($) $ in Thousands	6 Months Ended
	Sep. 30, 2015	Mar. 31, 2015
Maximum
Available-for-sale securities
Contractual maturity period	7 months
Short-term investments.
Available-for-sale securities
Amortized Cost	$ 7,694	$ 24,538
Gross Unrealized Gains		5
Gross Unrealized Losses		(10)
Fair Value	7,694	24,533
Short-term investments. | Corporate debentures/bonds
Available-for-sale securities
Amortized Cost	5,890	13,823
Gross Unrealized Losses		(10)
Fair Value	5,890	13,813
Short-term investments. | Government agency bonds
Available-for-sale securities
Amortized Cost	1,804	5,315
Gross Unrealized Gains		2
Fair Value	1,804	5,317
Short-term investments. | Treasury bills
Available-for-sale securities
Amortized Cost		5,400
Gross Unrealized Gains		3
Fair Value		5,403
Cash equivalents
Available-for-sale securities
Amortized Cost	58,755	51,784
Fair Value	58,755	51,784
Cash equivalents | Money market funds
Available-for-sale securities
Amortized Cost	58,755	51,784
Fair Value	$ 58,755	$ 51,784

XML

ACCOUNTING FOR STOCK-BASED COMPENSATION (Details) - USD ($)	3 Months Ended		6 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Stock-based compensation cost
Share-based compensation expense before tax	$ 710,000	$ 991,000	$ 1,044,000	$ 1,770,000
Income tax benefit recognized related to the compensation costs	249,000	332,000	366,000	593,000
Cost of sales and contracts
Stock-based compensation cost
Share-based compensation expense before tax	148,000	297,000	113,000	523,000
Selling, general and administrative expenses
Stock-based compensation cost
Share-based compensation expense before tax	$ 562,000	$ 694,000	$ 931,000	$ 1,247,000

XML

COMMITMENTS AND CONTINGENCIES (Details)	6 Months Ended
	Sep. 30, 2015
COMMITMENTS AND CONTINGENCIES.
Minimum period covered under extended warranty and service contracts	1 year
Maximum period covered under extended warranty and service contracts	5 years

XML

INCOME PER COMMON AND COMMON EQUIVALENT SHARE

6 Months Ended

Sep. 30, 2015

INCOME PER COMMON AND COMMON EQUIVALENT SHARE

INCOME PER COMMON AND COMMON EQUIVALENT SHARE

4.INCOME PER COMMON AND COMMON EQUIVALENT SHARE

Basic earnings per common share is computed by dividing distributed and undistributed earnings to common stockholders by the weighted average number of shares of common stock outstanding during the period.   Share-based payment awards entitling holders to receive non-forfeitable dividends before vesting are considered participating securities and thus are included in the calculation of basic earnings per share under the two-class method.  Diluted earnings per share include the dilutive impact of options, and restricted stock units using the average share price of the Company’s common stock for the period.  For the three months ended September 30, 2015 and September 30, 2014, common stock equivalents of 291,000 and 298,000 shares, respectively, are excluded from diluted earnings per share, as their effect is anti-dilutive. For the six months ended September 30, 2015 and September 30, 2014, common stock equivalents of 291,000 and 294,000 shares, respectively, are excluded from diluted earnings per share, as their effect is anti-dilutive.

	Three Months Ended					Six Months Ended
(In thousands except per share amounts)	September 30, 2015		September 30, 2014			September 30, 2015			September 30, 2014
Income (Loss) Per Share — Basic:
Net income (loss)	$	464	$	(3,906	)	$	(51	)	$	(2,452	)
Less: Distributed and undistributed earnings (loss) to unvested restricted stock units	7		—			(6		)	—
Distributed and undistributed earnings (loss) to common shareholders — Basic	457		(3,906		)	(45		)	(2,452		)
Weighted average number of common shares outstanding — basic	7,151		7,917			7,156			7,904
Net income (loss) per share — basic	$	0.06	$	(0.49	)	$	(0.01	)	$	(0.31	)
Diluted:
Weighted average number of common shares outstanding	7,151		7,917			7,156			7,904
Add dilutive effect of potential common shares	5		—			—			—
Weighted average number of common and potential common shares outstanding — diluted	7,156		7,917			7,156			7,904
Net income (loss) per share — diluted	$	0.06	$	(0.49	)	$	(0.01	)	$	(0.31	)

XML

INVENTORIES (Details) - USD ($) $ in Thousands	Sep. 30, 2015	Mar. 31, 2015
INVENTORIES
Raw materials, completed sub-assemblies, and spare parts	$ 20,451	$ 20,334
Work-in-process	13,092	17,853
Finished goods	4,786	2,796
Total	$ 38,329	$ 40,983

XML

ACCOUNTING FOR STOCK-BASED COMPENSATION (Details 4)	6 Months Ended
	Sep. 30, 2015 USD ($) $ / shares shares
Minimum
Stockholder's equity
Vesting period for awards granted under the plans	1 year
Maximum
Stockholder's equity
Vesting period for awards granted under the plans	3 years
Restricted Stock and Restricted Stock Units
Stockholder's equity
Unrecognized compensation costs (in dollars) | $	$ 6,578,000
Expected period to recognize unrecognized compensation costs	1 year 8 months 12 days
Number of Shares
Outstanding at the beginning of the period (in shares)	91,837
Granted (in shares)	119,439
Vested (in shares)	(15,332)
Forfeited (in shares)	(7,838)
Outstanding at the end of the period (in shares)	188,106
Weighted Average Grant Date Fair Value
Outstanding at the beginning of the period (in dollars per share) | $ / shares	$ 62.99
Granted (in dollars per share) | $ / shares	43.78
Vested (in dollars per share) | $ / shares	58.95
Forfeited (in dollars per share) | $ / shares	63.65
Outstanding at the end of the period (in dollars per share) | $ / shares	$ 51.09
Restricted Stock and Restricted Stock Units | Employees | Minimum
Stockholder's equity
Vesting period for awards granted under the plans	1 year
Restricted Stock and Restricted Stock Units | Employees | Maximum
Stockholder's equity
Vesting period for awards granted under the plans	3 years
Restricted Stock | Non-employee directors
Stockholder's equity
Vesting period for awards granted under the plans	1 year

XML

INCOME PER COMMON AND COMMON EQUIVALENT SHARE (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
INCOME PER COMMON AND COMMON EQUIVALENT SHARE
Common stock equivalents excluded from diluted earnings per share as their effect is anti-dilutive (in shares)	291,000	298,000	291,000	294,000
Income (Loss) Per Share - Basic:
Net income (loss)	$ 464	$ (3,906)	$ (51)	$ (2,452)
Less: Distributed and undistributed earnings (loss) to unvested	7		(6)
Distributed and undistributed earnings (loss) to common shareholders	$ 457	$ (3,906)	$ (45)	$ (2,452)
Weighted average number of common shares outstanding (in shares)	7,151,000	7,917,000	7,156,000	7,904,000
Net income (loss) per share - basic (in dollars per share)	$ 0.06	$ (0.49)	$ (0.01)	$ (0.31)
Diluted:
Weighted average number of common shares outstanding (in shares)	7,151,000	7,917,000	7,156,000	7,904,000
Add dilutive effect of potential common shares (in shares)	5,000
Weighted average number of common and potential common shares outstanding - diluted (in shares)	7,156,000	7,917,000	7,156,000	7,904,000
Net income (loss) per share - diluted (in dollars per share)	$ 0.06	$ (0.49)	$ (0.01)	$ (0.31)

XML

LETTERS OF CREDIT (Details) - USD ($)	Sep. 30, 2015	Mar. 31, 2015
Credit facilities
Long-term restricted cash, as determined by the expiration date of the underlying letters of credit	$ 231,000	$ 208,000
Standby letters of credit
Credit facilities
Outstanding Amount	10,817,000
Restricted cash balance	5,827,000
Long-term restricted cash, as determined by the expiration date of the underlying letters of credit	$ 231,000
Standby letters of credit | Minimum
Credit facilities
Percentage of outstanding amount that is cash secured	52.00%
Standby letters of credit | Maximum
Credit facilities
Percentage of outstanding amount that is cash secured	63.00%

XML

INVENTORIES

6 Months Ended

Sep. 30, 2015

INVENTORIES

INVENTORIES

3.INVENTORIES

Inventories consist of material, labor and manufacturing overhead and are recorded at the lower of cost, using the weighted average cost method, or net realizable value. Excess manufacturing overhead costs attributable to idle facility expenses, freight, handling costs and wasted material (spoilage) attributable to abnormally low production volumes (levels that materially differ from budgeted production plans due primarily to changes in customer demand) are excluded from inventory and recorded as an expense in the period incurred.

The components of inventories at September 30, 2015 and March 31, 2015 were as follows:

(In thousands)	September 30, 2015		March 31, 2015
Raw materials, completed sub-assemblies, and spare parts	$	20,451	$	20,334
Work-in-process	13,092		17,853
Finished goods	4,786		2,796
Total	$	38,329	$	40,983

XML

FAIR VALUE MEASUREMENTS (Details) - Recurring basis - USD ($) $ in Thousands	Sep. 30, 2015	Mar. 31, 2015
Total fair value
Financial Assets
Total cash equivalents and short-term investments	$ 66,449	$ 76,317
Level 1
Financial Assets
Total cash equivalents and short-term investments	58,755	57,187
Level 1 | Treasury bills
Financial Assets
Total cash equivalents and short-term investments		5,403
Level 1 | Money market funds
Financial Assets
Total cash equivalents and short-term investments	58,755	51,784
Level 2
Financial Assets
Total cash equivalents and short-term investments	7,694	19,130
Level 2 | Corporate debentures/bonds
Financial Assets
Total cash equivalents and short-term investments	5,890	13,813
Level 2 | Government agency bonds
Financial Assets
Total cash equivalents and short-term investments	$ 1,804	$ 5,317

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2015	Mar. 31, 2015
Current assets:
Cash and cash equivalents	$ 79,293	$ 68,835
Restricted cash	5,596	6,193
Short-term investments, at fair value	7,694	24,533
Accounts receivable, net of allowances of $250 and $333 at September 30, 2015 and March 31, 2015, respectively	20,873	22,124
Unbilled costs and fees	3,478	1,848
Inventories, net	38,329	40,983
Prepaid expenses and other current assets	8,823	10,701
Deferred income taxes	2,486	2,486
Total current assets	166,572	177,703
Equipment and leasehold improvements, net	7,117	8,711
Restricted cash	231	208
Deferred income taxes	5,952	5,952
Other assets, net	301	534
Total assets	180,173	193,108
Current liabilities:
Accounts payable	4,747	7,200
Accrued salaries and benefits	4,549	6,769
Accrued warranty costs	200	159
Deferred revenue	8,653	7,355
Customer deposits	11,557	13,956
Other current liabilities	4,579	5,736
Total current liabilities	34,285	41,175
Deferred revenue	3,344	1,019
Other long-term liabilities	622	507
Total liabilities	$ 38,251	$ 42,701
Stockholders' equity:
Preferred stock, no par value, 100,000 shares authorized; no shares issued
Common stock, $0.66 2/3 par value, 20,000,000 shares authorized; 7,163,642 and 7,193,247 shares issued and outstanding at September 30, 2015 and March 31, 2015, respectively	$ 4,775	$ 4,795
Capital in excess of par value	2,126	3,334
Accumulated other comprehensive loss, net	(7)	(11)
Retained earnings	135,028	142,289
Total stockholders' equity	141,922	150,407
Total liabilities and stockholders' equity	$ 180,173	$ 193,108

XML

GENERAL

6 Months Ended

Sep. 30, 2015

GENERAL

GENERAL

1.   GENERAL

The condensed consolidated financial statements include the accounts of American Science and Engineering, Inc. and its wholly owned subsidiaries (the “Company”). All significant intercompany transactions and balances have been eliminated.

The unaudited condensed consolidated financial statements have been prepared in accordance with the requirements of Form 10-Q and consequently do not include all disclosures required by Form 10-K. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2015, or fiscal 2015, as filed with the Securities and Exchange Commission on June 5, 2015.

The unaudited condensed consolidated financial statements, in the opinion of management, include all necessary adjustments, consisting solely of normal recurring adjustments, to present fairly the Company’s financial position, results of operations and cash flows.  These results are not necessarily indicative of the results to be expected for the entire year.

Nature of Operations

The Company develops, manufactures, markets, and sells X-ray inspection and other detection products for homeland security, force protection, public safety and other critical defense and security applications.  The Company provides maintenance, warranty, engineering, and training and operator services related to these products.  The Company has one reporting segment, X-ray screening products.

Significant Accounting Policies

For systems that are produced in a standard manufacturing operation and have shorter order to delivery cycles, the Company recognizes sales when title passes and when other revenue recognition criteria (such as transfer of risk and customer acceptance) are met.  Revenues on cost reimbursable and custom long-term fixed price contracts are generally recorded as costs are incurred using the percentage of completion method.

The other significant accounting policies followed by the Company and its subsidiaries in preparing its consolidated financial statements are set forth in Note 1 to the consolidated financial statements included in its Form 10-K for the year ended March 31, 2015.  There have been no changes to the Company’s critical accounting policies during the three and six months ended September 30, 2015.

Stock Repurchase Program

On May 7, 2013, the Board of Directors announced the approval of its fifth Stock Repurchase Program which authorized the Company to repurchase up to $35 million of shares of its common stock from time to time on the open market or in privately negotiated transactions.  On December 1, 2014, the Board of Directors announced an expansion of this stock repurchase program increasing the program authorization to $50 million of shares of its common stock.

During the three months ended June 30, 2015, the Company repurchased 54,056 shares of its common stock at an average price of $41.86.  During the three months ended September 30, 2015, the Company did not repurchase any shares of its common stock.  As of September 30, 2015, the remaining balance available under the Stock Repurchase Program was $11,225,000.

Dividends

	Three Months Ended				Six Months Ended
(In thousands)	September 30, 2015		September 30, 2014		September 30, 2015		September 30, 2014
Dividends declared	$	0.50	$	0.50	$	1.00	$	1.00
Dividends paid	$	0.50	$	0.50	$	1.00	$	1.00

On November 9, 2015, the Company declared a cash dividend of $0.50 per share. The dividend will be paid on December 2, 2015 to all shareholders of record at the close of business on November 24, 2015.  Future dividends will be declared at the discretion of the Board of Directors and will depend upon such factors as the Board of Directors deems relevant.

Concentrations of Credit Risk

Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents, restricted cash, short-term investments and accounts and unbilled receivables.  At times, the Company maintains cash balances in excess of insured limits. The Company maintains its cash and cash equivalents with major financial institutions.  The Company’s credit risk is managed by investing its cash in investment grade corporate debentures/bonds, U.S. government agency bonds, commercial paper, U.S. treasury bills, money market funds, and certificates of deposit.

New Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue From Contracts With Customers, which outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The ASU is based on the principle that an entity should recognize revenue in an amount that reflects the consideration to which an entity expects to be entitled in exchange for the goods or services transferred to its customers. The ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to fulfill a contract. Entities have the option of using either a full retrospective or a modified retrospective approach for the adoption of the new standard. The guidance is effective for annual periods beginning on or after December 15, 2017 (early adoption for annual periods beginning on or after December 15, 2016 is permitted). The Company is currently assessing the impact that this standard will have on its consolidated financial statements.

In January 2015 the FASB issued ASU No. 2015-01, Income Statement—Extraordinary and Unusual Items, which eliminates from U.S. GAAP the concept of extraordinary items.  Entities may apply the amendments prospectively or retrospectively to all prior periods presented in the financial statements. Early adoption is permitted.  ASU No. 2015-01 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015.  The adoption of this standard is not expected to have a material effect on the Company’s consolidated financial statements.

In July 2015, the FASB issued ASU No. 2015-11, Simplifying the Measurement of Inventory, which requires an entity to measure inventory at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Subsequent measurement is unchanged for inventory measured using last-in, first-out (“LIFO”) or the retail inventory method. It is effective for annual reporting periods beginning after December 15, 2016. The amendments should be applied prospectively with earlier application permitted as of the beginning of an interim or annual reporting period. The Company is currently assessing the impact that this standard will have on its consolidated financial statements.

XML

GUARANTEES (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
GUARANTEES
Warranty period for certain products			1 year
Historical experience trailing period based on how product warranty accrual rates are determined			12 months
Warranty Experience
Warranty accrual at beginning of period	$ 188	$ 246	$ 159	$ 404
Accruals for warranties issued during the period	83	43	174	85
Adjustment of preexisting accrual estimates	1	(16)	36	(160)
Warranty costs incurred during period	(72)	(87)	(169)	(143)
Warranty accrual at end of period	$ 200	$ 186	$ 200	$ 186

XML

GUARANTEES (Tables)

6 Months Ended

Sep. 30, 2015

GUARANTEES

Schedule of warranty experience

	Three Months Ended						Six Months Ended
(In thousands)	September 30, 2015			September 30, 2014			September 30, 2015			September 30, 2014
Warranty accrual - beginning of period	$	188		$	246		$	159		$	404
Accruals for warranties issued during the period	83			43			174			85
Adjustment of preexisting accrual estimates	1			(16		)	36			(160		)
Warranty costs incurred during the period	(72		)	(87		)	(169		)	(143		)
Warranty accrual — end of period	$	200		$	186		$	200		$	186

XML

LEASE COMMITMENTS (Details)	Oct. 31, 2014 USD ($)
LEASE COMMITMENTS
Gain deferred from the removal of building	$ 381,000

XML

GENERAL (Details 2) - USD ($)			3 Months Ended			6 Months Ended
	Dec. 02, 2015	Nov. 09, 2015	Sep. 30, 2015	Jun. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 01, 2014	May. 07, 2013
Dividends
Dividends declared (in dollars per share)		$ 0.50	$ 0.50		$ 0.50	$ 1.00	$ 1.00
Dividends paid (in dollars per share)			$ 0.50		$ 0.50	$ 1.00	$ 1.00
Forecast
Dividends
Dividends paid (in dollars per share)	$ 0.50
Stock Repurchase Program
Stock Repurchase Program
Number of shares repurchased under the stock repurchase program			0	54,056
Average price of shares repurchased				$ 41.86
Maximum dollar value of shares that may still be purchased under stock repurchase program			$ 11,225,000			$ 11,225,000
Fifth Stock Repurchase Program
Stock Repurchase Program
Authorized amount of repurchase of common stock								$ 50,000,000	$ 35,000,000

XML

ACCOUNTING FOR STOCK-BASED COMPENSATION

6 Months Ended

Sep. 30, 2015

ACCOUNTING FOR STOCK-BASED COMPENSATION

ACCOUNTING FOR STOCK-BASED COMPENSATION

2.   ACCOUNTING FOR STOCK-BASED COMPENSATION

The Company accounts for stock-based awards made to its employees and Board of Directors in accordance with FASB Accounting Standards Codification (“FASB ASC”) 718, Compensation—Stock Compensation, which requires the measurement and recognition of all compensation costs for stock-based awards made to employees and the Board of Directors based upon the grant date fair value over the requisite service period for awards expected to vest.

The Company recognized $710,000 and $991,000 of stock-based compensation costs for the three months ended September 30, 2015 and September 30, 2014, respectively.  The Company recognized $1,044,000 and $1,770,000 of stock-based compensation costs for the six months ended September 30, 2015 and September 30, 2014, respectively.  The income tax benefit recognized related to the compensation costs for the three months ended September 30, 2015 and September 30, 2014 was approximately $249,000 and $332,000 respectively.  The income tax benefit recognized related to the compensation costs for the six months ended September 30, 2015 and September 30, 2014 was approximately $366,000 and $593,000, respectively.

The following table summarizes stock-based compensation costs included in the Company’s consolidated statements of operations and comprehensive income (loss):

	Three Months Ended				Six Months Ended
(In thousands)	September 30, 2015		September 30, 2014		September 30, 2015		September 30, 2014
Cost of sales and contracts	$	148	$	297	$	113	$	523
Selling, general and administrative	562		694		931		1,247
Total share-based compensation expense before tax	$	710	$	991	$	1,044	$	1,770

Stock Option and Other Compensation Plans

The Company has various stock option and other compensation plans for directors, officers, and employees.  The Company had the following stock plans outstanding as of September 30, 2015: the 2003 Stock Plan for Non-Employee Directors, the 2005 Equity and Incentive Plan and the 2014 Equity and Incentive Plan. There are 367,000 shares remaining available for issuance under these plans. Vesting periods are at the discretion of the Board of Directors and typically range from one to three years.  Options under these plans are granted at fair market value and have a term of ten years from the date of grant.

Stock Options

The following tables summarize stock option activity for the six months ended September 30, 2015:

	Number of Shares		Weighted Average Exercise Price ($)		Weighted Average Contractual Life (years)	Aggregate Intrinsic Value
Options outstanding at March 31, 2015	191,834		$	66.03	2.88
Grants	—		—
Exercises	—		—			—
Cancellations	(4,721	)	56.92
Options outstanding at September 30, 2015	187,113		$	66.26	2.42
Options exercisable at September 30, 2015	187,113

Information related to the stock options outstanding as of September 30, 2015 is as follows:

Range of Exercise Prices	Number of Shares	Weighted-Average Remaining Contractual Life (years)	Weighted-Average Exercise Price ($)		Exercisable Number of Shares	Exercisable Weighted-Average Exercise Price ($)
$ 53.55-$60.00	24,450	0.07	$	53.55	24,450	$	53.55
$ 60.01-$75.82	162,663	2.78	68.17		162,663	68.17
$ 53.55-$75.82	187,113	2.42	$	66.26	187,113	$	66.26

The Company deems the Black-Scholes option pricing model as the most appropriate method for determining the estimated fair value of stock-based awards. The Black-Scholes method of valuation requires several assumptions: (1) the expected term of the stock-based award; (2) the expected future stock volatility over the expected term; (3) a risk-free interest rate; and (4) the expected dividend yield. The expected term represents the expected period of time that the Company believes the options will be outstanding based on historical information. Estimates of expected future stock price volatility are based on the historic volatility of the Company’s common stock and the risk-free interest rate is based on the U.S. Zero-Bond rate.

There were no options granted in the three or six month period ended September 30, 2015.

As of September 30, 2015, there was no remaining unrecognized compensation cost related to options granted.

Restricted Stock and Restricted Stock Units

The Company has instituted long-term incentive plans for certain key employees. These plans call for the issuance of restricted stock, restricted stock units, restricted stock options, and/or cash incentives which vest or are paid upon the achievement of certain performance-based goals as well as service time incurred.  Restricted stock and restricted stock units may also be granted to other employees with vesting periods that range from one to three years.  In addition, annually the non-employee directors are granted restricted stock. Restricted stock shares granted to our non-employee directors vest on a pro-rata basis, based on service performed over a one-year period. Certain of the stock and stock unit awards contain rights to receive non-forfeitable dividends. The fair values of the restricted stock and restricted stock unit awards are equal to the fair value of the Company’s common stock on the date of grant.

Non-vested restricted stock and restricted stock unit awards are subject to the risk of forfeiture until the fulfillment of specified conditions. As of September 30, 2015, there was $6,578,000 of total unrecognized compensation costs related to non-vested restricted stock and restricted stock unit awards granted under the Company’s stock plans. These costs are expected to be recognized over a weighted average period of 1.7 years.

The following table summarizes the status of the Company’s non-vested restricted stock and restricted stock unit awards for the six months ended September 30, 2015:

	Number of Shares		Weighted Average Grant Date Fair Value ($)
Outstanding at March 31, 2015	91,837		$	62.99
Granted	119,439		43.78
Vested	(15,332	)	58.95
Forfeited	(7,838	)	63.65
Outstanding at September 30, 2015	188,106		$	51.09

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2015	Mar. 31, 2015
CONDENSED CONSOLIDATED BALANCE SHEETS
Accounts receivable, allowances (in dollars)	$ 250	$ 333
Preferred stock, no par value (in dollars per share)	$ 0	$ 0
Preferred stock, shares authorized	100,000	100,000
Preferred stock, shares issued	0	0
Common stock, par value (in dollars per share)	$ 0.6666	$ 0.6666
Common stock, shares authorized	20,000,000	20,000,000
Common stock, shares issued	7,163,642	7,193,247
Common stock, shares outstanding	7,163,642	7,193,247

XML

GENERAL (Tables)

6 Months Ended

Sep. 30, 2015

GENERAL

Schedule of dividends

	Three Months Ended				Six Months Ended
(In thousands)	September 30, 2015		September 30, 2014		September 30, 2015		September 30, 2014
Dividends declared	$	0.50	$	0.50	$	1.00	$	1.00
Dividends paid	$	0.50	$	0.50	$	1.00	$	1.00

XML

Document and Entity Information - shares	6 Months Ended
	Sep. 30, 2015	Nov. 03, 2015
Document and Entity Information
Entity Registrant Name	AMERICAN SCIENCE & ENGINEERING, INC.
Entity Central Index Key	0000005768
Document Type	10-Q
Document Period End Date	Sep. 30, 2015
Amendment Flag	false
Current Fiscal Year End Date	--03-31
Entity Current Reporting Status	Yes
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		7,167,424
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q2

XML

ACCOUNTING FOR STOCK-BASED COMPENSATION (Tables)

6 Months Ended

Sep. 30, 2015

ACCOUNTING FOR STOCK-BASED COMPENSATION

Summary of stock-based compensation costs in the statements of operations and comprehensive income (loss)

	Three Months Ended				Six Months Ended
(In thousands)	September 30, 2015		September 30, 2014		September 30, 2015		September 30, 2014
Cost of sales and contracts	$	148	$	297	$	113	$	523
Selling, general and administrative	562		694		931		1,247
Total share-based compensation expense before tax	$	710	$	991	$	1,044	$	1,770

Summary of stock option activity

	Number of Shares		Weighted Average Exercise Price ($)		Weighted Average Contractual Life (years)	Aggregate Intrinsic Value
Options outstanding at March 31, 2015	191,834		$	66.03	2.88
Grants	—		—
Exercises	—		—			—
Cancellations	(4,721	)	56.92
Options outstanding at September 30, 2015	187,113		$	66.26	2.42
Options exercisable at September 30, 2015	187,113

Schedule of information related to stock options by exercise price range

Range of Exercise Prices	Number of Shares	Weighted-Average Remaining Contractual Life (years)	Weighted-Average Exercise Price ($)		Exercisable Number of Shares	Exercisable Weighted-Average Exercise Price ($)
$ 53.55-$60.00	24,450	0.07	$	53.55	24,450	$	53.55
$ 60.01-$75.82	162,663	2.78	68.17		162,663	68.17
$ 53.55-$75.82	187,113	2.42	$	66.26	187,113	$	66.26

Summary of the status of the non-vested restricted stock and stock unit awards

	Number of Shares		Weighted Average Grant Date Fair Value ($)
Outstanding at March 31, 2015	91,837		$	62.99
Granted	119,439		43.78
Vested	(15,332	)	58.95
Forfeited	(7,838	)	63.65
Outstanding at September 30, 2015	188,106		$	51.09

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Net sales and contract revenues:
Net product sales and contract revenues	$ 13,425	$ 11,004	$ 32,566	$ 34,255
Net service revenues	11,712	12,062	24,015	24,348
Total net sales and contract revenues	25,137	23,066	56,581	58,603
Cost of sales and contracts:
Cost of product sales and contracts	7,045	6,531	17,665	18,829
Cost of service revenues	5,738	6,852	12,136	13,622
Total cost of sales and contracts	12,783	13,383	29,801	32,451
Gross profit	12,354	9,683	26,780	26,152
Expenses:
Selling, general and administrative expenses	6,772	9,118	15,042	17,309
Research and development costs	4,751	6,418	11,640	12,424
Total operating expenses	11,523	15,536	26,682	29,733
Operating income (loss)	831	(5,853)	98	(3,581)
Other income (expense):
Interest and investment income	55	87	89	165
Interest expense		(9)		(19)
Other, net	(172)	(99)	(265)	(252)
Total other expense	(117)	(21)	(176)	(106)
Income (loss) before provision for (benefit from) income taxes	714	(5,874)	(78)	(3,687)
Provision for (benefit from) income taxes	250	(1,968)	(27)	(1,235)
Net income (loss)	464	(3,906)	(51)	(2,452)
Other comprehensive income (loss):
Unrealized gain (loss) on available for sale securities (net of tax)	3	(15)	4	(29)
Comprehensive income (loss)	$ 467	$ (3,921)	$ (47)	$ (2,481)
Income (loss) per share - Basic (in dollars per share)	$ 0.06	$ (0.49)	$ (0.01)	$ (0.31)
Income (loss) per share - Diluted (in dollars per share)	$ 0.06	$ (0.49)	$ (0.01)	$ (0.31)
Weighted average shares - Basic (in shares)	7,151	7,917	7,156	7,904
Weighted average shares - Diluted (in shares)	7,156	7,917	7,156	7,904
Dividends declared per share (in dollars per share)	$ 0.50	$ 0.50	$ 1.00	$ 1.00

XML

INCOME TAXES

6 Months Ended

Sep. 30, 2015

INCOME TAXES

INCOME TAXES

7.   INCOME TAXES

The Company accounts for income taxes in accordance with FASB ASC 740, Income Taxes, and recognizes deferred income taxes based on the expected future tax consequences of differences between the financial statement basis and the tax basis of assets and liabilities, calculated using enacted tax rates in effect for the year in which the differences are expected to be reflected in the tax return. The Company evaluates the need for a valuation allowance against its net deferred tax assets at period end based upon its three year cumulative income and its projections of future income, and records a valuation allowance against any net deferred tax assets if it is more likely than not that they will not be realized.

The Company is currently open to audit under the statute of limitations by the Internal Revenue Service for the years ending March 31, 2012 through 2014 and by various state taxing authorities for the years ending March 31, 2011 through 2014.

XML

FAIR VALUE MEASUREMENTS

6 Months Ended

Sep. 30, 2015

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS

6.   FAIR VALUE MEASUREMENTS

The Company has categorized its financial assets, based on the priority of the inputs to the valuation technique, into a three-level fair value hierarchy as set forth below. If the inputs used to measure a financial instrument fall within different levels of the hierarchy, the categorization of such financial asset is based on the lowest level input that is significant to the fair value measurement of such instrument.

Financial assets are categorized based on the inputs to the valuation techniques as follows:

Level 1 - Financial assets whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the Company has the ability to access at the measurement date (examples include actively exchange-traded equity securities, listed derivatives, and most U.S. government and agency securities).

Level 2 - Financial assets whose values are based on quoted prices in markets where trading occurs infrequently or whose values are based on quoted prices of instruments with similar attributes in active markets.  Level 2 inputs include the following:

    Quoted prices for identical or similar assets or liabilities in non-active markets;

    Inputs other than quoted prices that are observable for substantially the full term of the asset or liability; and

    Inputs that are derived principally from or corroborated by observable market data for substantially the full term of the asset or liability.

Level 3 - Financial assets whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s assumptions about the assumptions a market participant would use in pricing the asset or liability. The Company currently does not have any Level 3 financial assets or liabilities.

The following table presents the financial assets that the Company measures at fair value on a recurring basis, based on the fair value hierarchy as of September 30, 2015 and March 31, 2015:

(In thousands)	September 30, 2015		March 31, 2015
Level 1 — Financial Assets
Money market funds	$	58,755	$	51,784
Treasury bills	—		5,403
Total Level 1 Financial Assets	58,755		57,187
Level 2 — Financial Assets
Corporate debentures/bonds	5,890		13,813
Government agency bonds	1,804		5,317
Total Level 2 Financial Assets	7,694		19,130
Total cash equivalents and short-term investments	$	66,449	$	76,317

Short-term investments are classified as available-for-sale and are recorded at their fair market values using the specific identification method. As of September 30, 2015, all of the Company’s available-for-sale securities had contractual maturities of seven months or less. The Company had no material realized gains or losses on its available-for-sale securities for the three and six months ended September 30, 2015 and September 30, 2014. The unrealized holding gains or losses on these securities are included as a component of other comprehensive income (loss), as disclosed in the condensed consolidated statements of operations and comprehensive income (loss).

(In thousands)	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
September 30, 2015:
Short-term investments:
Corporate debentures/bonds	$	5,890	$	—	$	—	$	5,890
Government agency bonds	1,804		—		—		1,804
Total short-term investments	$	7,694	$	—	$	—	$	7,694
Cash equivalents:
Money market funds	$	58,755	—		—		$	58,755
Total cash equivalents	$	58,755	$	—	$	—	$	58,755

(In thousands)	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
March 31, 2015:
Short-term investments:
Corporate debentures/bonds	$	13,823	$	—	$	(10	)	$	13,813
Government agency bonds	5,315		2		—			5,317
Treasury bills	5,400		3		—			5,403
Total short-term investments	$	24,538	$	5	$	(10	)	$	24,533
Cash equivalents:
Money market funds	$	51,784	$	—	$	—		$	51,784
Total cash equivalents	$	51,784	$	—	$	—		$	51,784

XML

GENERAL (Details)	6 Months Ended
	Sep. 30, 2015 segment
Nature of Operations
Number of reporting segments	1

XML

INVENTORIES (Tables)

6 Months Ended

Sep. 30, 2015

INVENTORIES

Schedule of components of inventories

(In thousands)	September 30, 2015		March 31, 2015
Raw materials, completed sub-assemblies, and spare parts	$	20,451	$	20,334
Work-in-process	13,092		17,853
Finished goods	4,786		2,796
Total	$	38,329	$	40,983

XML

COMMITMENTS AND CONTINGENCIES

6 Months Ended

Sep. 30, 2015

COMMITMENTS AND CONTINGENCIES.

COMMITMENTS AND CONTINGENCIES

10.   COMMITMENTS AND CONTINGENCIES

Deferred Revenue

The Company offers extended warranty and service contracts to its customers. These contracts typically cover a period of one to five years, and include advance payments that are recorded as deferred revenue. Revenue is recognized as services are performed over the life of the contract, which represents the period over which these revenues are earned. Costs associated with these extended warranty and service contracts are expensed to cost of sales and contracts as incurred.

Legal Matters

The Company continues to respond to the subpoena received from the Office of the Inspector General (“OIG”) of the U.S. General Services Administration (“GSA”) on April 17, 2015 with respect to the investigation being conducted by the GSA and the Department of Defense.  The investigation relates to the Company’s discount practices and compliance with the pricing provisions of the Company’s GSA Schedule contract. The Company continues to cooperate fully with the investigation and at this time management is unable to predict the outcome of the investigation or estimate the amount of possible loss or range of loss with any certainty.  It is possible that the investigation could lead to claims or findings of violations of the False Claims Act in connection with the Company’s GSA contracting activity. Violations of the False Claims Act could result in the imposition of damages, including up to treble damages, plus civil penalties in some cases. The Company has incurred, and will continue to incur, legal costs in connection with the investigation, and could incur other costs, damages or penalties, depending on its outcome, which could be material.

XML

GUARANTEES

6 Months Ended

Sep. 30, 2015

GUARANTEES

GUARANTEES

8.GUARANTEES

Certain of the Company’s products carry a one-year warranty, the costs of which are accrued for at the time of shipment or delivery.  Accrual rates are based upon historical experience for the trailing twelve months and management’s judgment of future exposure.  Warranty experience for the three and six months ended September 30, 2015 and 2014 was as follows:

	Three Months Ended						Six Months Ended
(In thousands)	September 30, 2015			September 30, 2014			September 30, 2015			September 30, 2014
Warranty accrual - beginning of period	$	188		$	246		$	159		$	404
Accruals for warranties issued during the period	83			43			174			85
Adjustment of preexisting accrual estimates	1			(16		)	36			(160		)
Warranty costs incurred during the period	(72		)	(87		)	(169		)	(143		)
Warranty accrual — end of period	$	200		$	186		$	200		$	186

XML

LEASE COMMITMENTS

6 Months Ended

Sep. 30, 2015

LEASE COMMITMENTS

LEASE COMMITMENTS

9.   LEASE COMMITMENTS

In March 2005, the Company renewed its lease agreement for its corporate headquarters and manufacturing facilities in Billerica, Massachusetts.  As part of the lease agreement, the Company’s landlord agreed to certain renovations to the Billerica facility including the construction of additional high bay manufacturing space.  The Company was responsible for a portion of the construction costs and was deemed to be the owner of the building during the construction period under FASB ASC 840, Leases.

In October 2014, the Company entered into an amendment of its lease agreement for the Billerica facilities extending the term of the lease through February 28, 2023 with an adjusted rent schedule commencing October 1, 2014. Due to certain provisions of the amended lease agreements which removed certain continuing financing obligations related to the building, it was determined that the lease no longer qualified as a capital lease and as such, the Company removed the capitalized building, associated accumulated depreciation and lease financing liability from its books.  The associated gain of $381,000 resulting from the removal of the building from our books was deferred and is being amortized over the modified lease term of the property.

XML

GENERAL (Policies)

6 Months Ended

Sep. 30, 2015

GENERAL

Nature of Operations and Basis of Presentation

The condensed consolidated financial statements include the accounts of American Science and Engineering, Inc. and its wholly owned subsidiaries (the “Company”). All significant intercompany transactions and balances have been eliminated.

The unaudited condensed consolidated financial statements have been prepared in accordance with the requirements of Form 10-Q and consequently do not include all disclosures required by Form 10-K. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2015, or fiscal 2015, as filed with the Securities and Exchange Commission on June 5, 2015.

The unaudited condensed consolidated financial statements, in the opinion of management, include all necessary adjustments, consisting solely of normal recurring adjustments, to present fairly the Company’s financial position, results of operations and cash flows.  These results are not necessarily indicative of the results to be expected for the entire year.

Nature of Operations

The Company develops, manufactures, markets, and sells X-ray inspection and other detection products for homeland security, force protection, public safety and other critical defense and security applications.  The Company provides maintenance, warranty, engineering, and training and operator services related to these products.  The Company has one reporting segment, X-ray screening products.

Revenue Recognition

For systems that are produced in a standard manufacturing operation and have shorter order to delivery cycles, the Company recognizes sales when title passes and when other revenue recognition criteria (such as transfer of risk and customer acceptance) are met.  Revenues on cost reimbursable and custom long-term fixed price contracts are generally recorded as costs are incurred using the percentage of completion method.

The other significant accounting policies followed by the Company and its subsidiaries in preparing its consolidated financial statements are set forth in Note 1 to the consolidated financial statements included in its Form 10-K for the year ended March 31, 2015.  There have been no changes to the Company’s critical accounting policies during the three and six months ended September 30, 2015.

Stock Repurchase Program and Dividends

Stock Repurchase Program

On May 7, 2013, the Board of Directors announced the approval of its fifth Stock Repurchase Program which authorized the Company to repurchase up to $35 million of shares of its common stock from time to time on the open market or in privately negotiated transactions.  On December 1, 2014, the Board of Directors announced an expansion of this stock repurchase program increasing the program authorization to $50 million of shares of its common stock.

During the three months ended June 30, 2015, the Company repurchased 54,056 shares of its common stock at an average price of $41.86.  During the three months ended September 30, 2015, the Company did not repurchase any shares of its common stock.  As of September 30, 2015, the remaining balance available under the Stock Repurchase Program was $11,225,000.

Dividends

	Three Months Ended				Six Months Ended
(In thousands)	September 30, 2015		September 30, 2014		September 30, 2015		September 30, 2014
Dividends declared	$	0.50	$	0.50	$	1.00	$	1.00
Dividends paid	$	0.50	$	0.50	$	1.00	$	1.00

On November 9, 2015, the Company declared a cash dividend of $0.50 per share. The dividend will be paid on December 2, 2015 to all shareholders of record at the close of business on November 24, 2015.  Future dividends will be declared at the discretion of the Board of Directors and will depend upon such factors as the Board of Directors deems relevant.

Concentrations of Credit Risk

Concentrations of Credit Risk

Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents, restricted cash, short-term investments and accounts and unbilled receivables.  At times, the Company maintains cash balances in excess of insured limits. The Company maintains its cash and cash equivalents with major financial institutions.  The Company’s credit risk is managed by investing its cash in investment grade corporate debentures/bonds, U.S. government agency bonds, commercial paper, U.S. treasury bills, money market funds, and certificates of deposit.

New Accounting Pronouncements

New Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue From Contracts With Customers, which outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The ASU is based on the principle that an entity should recognize revenue in an amount that reflects the consideration to which an entity expects to be entitled in exchange for the goods or services transferred to its customers. The ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to fulfill a contract. Entities have the option of using either a full retrospective or a modified retrospective approach for the adoption of the new standard. The guidance is effective for annual periods beginning on or after December 15, 2017 (early adoption for annual periods beginning on or after December 15, 2016 is permitted). The Company is currently assessing the impact that this standard will have on its consolidated financial statements.

In January 2015 the FASB issued ASU No. 2015-01, Income Statement—Extraordinary and Unusual Items, which eliminates from U.S. GAAP the concept of extraordinary items.  Entities may apply the amendments prospectively or retrospectively to all prior periods presented in the financial statements. Early adoption is permitted.  ASU No. 2015-01 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015.  The adoption of this standard is not expected to have a material effect on the Company’s consolidated financial statements.

In July 2015, the FASB issued ASU No. 2015-11, Simplifying the Measurement of Inventory, which requires an entity to measure inventory at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Subsequent measurement is unchanged for inventory measured using last-in, first-out (“LIFO”) or the retail inventory method. It is effective for annual reporting periods beginning after December 15, 2016. The amendments should be applied prospectively with earlier application permitted as of the beginning of an interim or annual reporting period. The Company is currently assessing the impact that this standard will have on its consolidated financial statements.

XML

INCOME TAXES (Details)	6 Months Ended
	Sep. 30, 2015
INCOME TAXES
Number of years of cumulative income based upon which valuation allowance is evaluated	3 years

XML

FAIR VALUE MEASUREMENTS (Tables)

6 Months Ended

Sep. 30, 2015

FAIR VALUE MEASUREMENTS

Schedule of financial assets measured at fair value on recurring basis, based on the fair value hierarchy

(In thousands)	September 30, 2015		March 31, 2015
Level 1 — Financial Assets
Money market funds	$	58,755	$	51,784
Treasury bills	—		5,403
Total Level 1 Financial Assets	58,755		57,187
Level 2 — Financial Assets
Corporate debentures/bonds	5,890		13,813
Government agency bonds	1,804		5,317
Total Level 2 Financial Assets	7,694		19,130
Total cash equivalents and short-term investments	$	66,449	$	76,317

Schedule of available-for-sale securities

(In thousands)	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
September 30, 2015:
Short-term investments:
Corporate debentures/bonds	$	5,890	$	—	$	—	$	5,890
Government agency bonds	1,804		—		—		1,804
Total short-term investments	$	7,694	$	—	$	—	$	7,694
Cash equivalents:
Money market funds	$	58,755	—		—		$	58,755
Total cash equivalents	$	58,755	$	—	$	—	$	58,755

(In thousands)	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
March 31, 2015:
Short-term investments:
Corporate debentures/bonds	$	13,823	$	—	$	(10	)	$	13,813
Government agency bonds	5,315		2		—			5,317
Treasury bills	5,400		3		—			5,403
Total short-term investments	$	24,538	$	5	$	(10	)	$	24,533
Cash equivalents:
Money market funds	$	51,784	$	—	$	—		$	51,784
Total cash equivalents	$	51,784	$	—	$	—		$	51,784

XML

ACCOUNTING FOR STOCK-BASED COMPENSATION (Details 2) - USD ($)	3 Months Ended	6 Months Ended	12 Months Ended
	Sep. 30, 2015	Sep. 30, 2015	Mar. 31, 2015
Stock Option and Other Compensation Plans
Number of shares that remain available for future issuance under the plans	367,000	367,000
Minimum
Stock Option and Other Compensation Plans
Vesting period for awards granted under the plans		1 year
Maximum
Stock Option and Other Compensation Plans
Vesting period for awards granted under the plans		3 years
Stock options
Stock Option and Other Compensation Plans
Term of awards from the date of grant		10 years
Number of Shares
Options outstanding at the beginning of the period (in shares)		191,834
Grants (in shares)	0	0
Cancellations (in shares)		(4,721)
Options outstanding at the end of the period (in shares)	187,113	187,113	191,834
Options exercisable at the end of the period (in shares)	187,113	187,113
Weighted Average Exercise Price
Options outstanding at the beginning of the period (in dollars per share)		$ 66.03
Cancellations (in dollars per share)		56.92
Options outstanding at the end of the period (in dollars per share)	$ 66.26	$ 66.26	$ 66.03
Weighted Average Contractual Life
Options outstanding at the end of the period		2 years 5 months 1 day	2 years 10 months 17 days
Remaining unrecognized compensation cost (in dollars)	$ 0	$ 0

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net loss	$ (51)	$ (2,452)
Adjustments to reconcile net loss to net cash provided by (used for) operating activities:
Depreciation and amortization	1,965	2,605
Provisions for contracts, inventory and accounts receivable reserves	(80)	(270)
Amortization of bond premium	63	540
Stock compensation expense	1,044	1,770
Other	202
Changes in assets and liabilities:
Accounts receivable	1,326	4,878
Unbilled costs and fees	(1,630)	(3,272)
Inventories	2,659	(11,534)
Prepaid expenses and other assets	2,111	(5,436)
Accounts payable	(2,453)	(6,762)
Accrued income taxes		(2,338)
Customer deposits	(2,399)	5,433
Deferred revenue	3,623	(1,847)
Accrued expenses and other liabilities	(3,221)	(7,274)
Net cash provided by (used for) operating activities	3,159	(25,959)
Cash flows from investing activities:
Purchases of short-term investments		(29,212)
Proceeds from sales and maturities of short-term investments	16,780	40,933
Purchases of property and equipment, net	(573)	(943)
Net cash provided by investing activities	16,207	10,778
Cash flows from financing activities:
Decrease in restricted cash	574	726
Proceeds from exercise of stock options		888
Repurchase of shares of common stock	(2,263)
Repayment of leasehold financing liability		(754)
Payment of common stock dividend	(7,219)	(7,993)
Net cash used for financing activities	(8,908)	(7,133)
Net increase (decrease) in cash and cash equivalents	10,458	(22,314)
Cash and cash equivalents at beginning of period	68,835	62,143
Cash and cash equivalents at end of period	$ 79,293	$ 39,829

XML

LETTERS OF CREDIT

6 Months Ended

Sep. 30, 2015

LETTERS OF CREDIT

LETTERS OF CREDIT

5.   LETTERS OF CREDIT

In the normal course of business, the Company may provide certain customers and potential customers with performance guarantees, which are generally backed by standby letters of credit. In general, the Company would only be liable for the amount of these guarantees in the event of default in the performance of its obligations, the probability of which management believes is low.   As of September 30, 2015, the Company had outstanding $10,817,000 in standby letters of credit.  These outstanding standby letters of credit are cash-secured at amounts ranging from 52% to 63% of the outstanding letters of credit, resulting in restricted cash balance of $5,827,000 at September 30, 2015, of which $231,000 was considered long-term restricted cash and investments due to the expiration date of the underlying letters of credit.

XML

ACCOUNTING FOR STOCK-BASED COMPENSATION (Details 3) - Stock options	6 Months Ended
	Sep. 30, 2015 $ / shares shares
53.55-$60.00
Information related to the stock options outstanding
Exercise price, low end of range (in dollars per share)	$ 53.55
Exercise price, high end of range (in dollars per share)	$ 60.00
Number of Shares | shares	24,450
Weighted-Average Remaining Contractual Life	26 days
Weighted-Average Exercise Price (in dollars per share)	$ 53.55
Exercisable Number of Shares | shares	24,450
Exercisable Weighted-Average Exercise Price (in dollars per share)	$ 53.55
$60.01-$75.82
Information related to the stock options outstanding
Exercise price, low end of range (in dollars per share)	60.01
Exercise price, high end of range (in dollars per share)	$ 75.82
Number of Shares | shares	162,663
Weighted-Average Remaining Contractual Life	2 years 9 months 11 days
Weighted-Average Exercise Price (in dollars per share)	$ 68.17
Exercisable Number of Shares | shares	162,663
Exercisable Weighted-Average Exercise Price (in dollars per share)	$ 68.17
$53.55-$75.82
Information related to the stock options outstanding
Exercise price, low end of range (in dollars per share)	53.55
Exercise price, high end of range (in dollars per share)	$ 75.82
Number of Shares | shares	187,113
Weighted-Average Remaining Contractual Life	2 years 5 months 1 day
Weighted-Average Exercise Price (in dollars per share)	$ 66.26
Exercisable Number of Shares | shares	187,113
Exercisable Weighted-Average Exercise Price (in dollars per share)	$ 66.26

XML

INCOME PER COMMON AND COMMON EQUIVALENT SHARE (Tables)

6 Months Ended

Sep. 30, 2015

INCOME PER COMMON AND COMMON EQUIVALENT SHARE

Schedule of calculation of basic and diluted earnings per share

	Three Months Ended					Six Months Ended
(In thousands except per share amounts)	September 30, 2015		September 30, 2014			September 30, 2015			September 30, 2014
Income (Loss) Per Share — Basic:
Net income (loss)	$	464	$	(3,906	)	$	(51	)	$	(2,452	)
Less: Distributed and undistributed earnings (loss) to unvested restricted stock units	7		—			(6		)	—
Distributed and undistributed earnings (loss) to common shareholders — Basic	457		(3,906		)	(45		)	(2,452		)
Weighted average number of common shares outstanding — basic	7,151		7,917			7,156			7,904
Net income (loss) per share — basic	$	0.06	$	(0.49	)	$	(0.01	)	$	(0.31	)
Diluted:
Weighted average number of common shares outstanding	7,151		7,917			7,156			7,904
Add dilutive effect of potential common shares	5		—			—			—
Weighted average number of common and potential common shares outstanding — diluted	7,156		7,917			7,156			7,904
Net income (loss) per share — diluted	$	0.06	$	(0.49	)	$	(0.01	)	$	(0.31	)